Last Updated: May 1, 2026

Drug Price Trends for CALAMINE SUSPENSION


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for CALAMINE SUSPENSION

Average Pharmacy Cost for CALAMINE SUSPENSION

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
CALAMINE SUSPENSION 24385-0413-96 0.00997 ML 2026-04-22
CALAMINE SUSPENSION 24385-0413-96 0.01043 ML 2026-03-18
CALAMINE SUSPENSION 24385-0413-96 0.01068 ML 2026-02-18
CALAMINE SUSPENSION 24385-0413-96 0.01055 ML 2026-01-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Calamine Suspension

Last updated: February 19, 2026

Calamine suspension is a topical dermatological medication primarily used to treat minor skin irritations such as itching, sunburns, and insect bites. It combines zinc oxide and ferric oxide, which provide soothing, anti-itch, and drying effects.

Market Overview

Current Market Size

The global dermatological market was valued at approximately $20 billion in 2022, growing at a compound annual growth rate (CAGR) of 4.5% from 2018 to 2022 [1]. Calamine-based products account for a niche segment within this market, predominantly in over-the-counter (OTC) formulations.

Key Market Segments

  • OTC skin care products: The majority of calamine suspension sales, used for common skin irritations.
  • Prescription medications: Limited use, mainly for severe dermatitis or specific dermatological conditions.
  • Geography:
    • North America: Largest market share, driven by OTC demand.
    • Europe: Increasing use, especially in traditional medicine markets.
    • Asia-Pacific: Growing demand, driven by rising skin conditions and OTC product use.

Distribution Channels

  • Pharmacy chains and drugstores.
  • Online retail platforms, accounting for 15-20% of OTC sales.
  • Hospitals and clinics for prescription uses in certain cases.

Competitive Landscape

Major producers include Johnson & Johnson, Merck, and local generic manufacturers. Market entry barriers are low due to the availability of existing formulations and OTC regulation ease in many regions.

Regulatory Environment

  • United States: Over-the-counter (OTC) monograph approved, with combined zinc oxide and ferric oxide formulations classified as Generally Recognized As Safe and Effective (GRASE).
  • European Union: Similar OTC approval pathways through the European Medicines Agency (EMA).
  • India and emerging markets: Unregulated or less stringent regulation, enabling rapid market penetration.

Price Dynamics

Current Pricing Trends

  • The average retail price for a 120 ml bottle of calamine suspension ranges from $5 to $10 in the U.S. and Europe [2].
  • Generic formulations are priced approximately 20-30% lower than branded products.
  • Online channels offer discounts of up to 15-20% relative to brick-and-mortar pharmacies.

Factors Influencing Price

  • Brand recognition and formulation quality.
  • Packaging and additional ingredients.
  • Distribution channel margins.
  • Regional regulatory costs and tariffs.

Price Projections (2023-2028)

Year Estimated Price Range (per 120 ml bottle) Remarks
2023 $5 - $10 Current stable prices, slight increased competition expected
2024 $4.80 - $9.80 Introduction of generic versions pressures prices downward
2025 $4.50 - $9.50 Further generic entry and online sales impact prices
2026 $4.20 - $9.20 Margins decrease, markets consolidate
2027 $4 - $9 Potential price stabilization; moderate growth in emerging markets
2028 $3.80 - $8.80 Price erosion due to increased generic products and online sales

Cost Factors

  • Raw material prices (zinc oxide, ferric oxide): Potential inflationary pressure.
  • Regulatory compliance costs: Remain relatively stable.
  • Manufacturing efficiency: Economies of scale could reduce costs, enabling lower prices.

Opportunities and Risks

Opportunities

  • Expanding presence in emerging markets with rising skin ailments.
  • Developing combination products to increase consumer value.
  • Leveraging e-commerce platforms for cost-effective distribution.

Risks

  • Regulatory tightening in key markets demanding stricter manufacturing standards.
  • Price competition intensifying with the entry of generics.
  • Consumer preference shift toward alternative or natural remedies.

Key Takeaways

  • The global market for calamine suspension remains niche but stable, with OTC significance.
  • Prices are under pressure from generic competition and online sales, with an overall trend toward reduction.
  • Regional markets show differential growth prospects, with Asia-Pacific and emerging markets offering high near-term growth potential.
  • Price projections suggest a gradual decline, stabilizing around $4 for a 120 ml bottle by 2028.
  • Manufacturers should focus on cost efficiency, brand differentiation, and online channels to maintain margins.

FAQs

Q1: What is the main use of calamine suspension?
A: It treats minor skin irritations such as itching, sunburns, and insect bites.

Q2: How is the market for calamine suspension expected to evolve?
A: Demand will continue in OTC markets with price erosion driven by generics but will grow in emerging markets.

Q3: What are the regulatory hurdles for calamine suspension?
A: It is generally classified as OTC and has few regulatory barriers, though regional variations exist.

Q4: How does online retail influence calamine suspension pricing?
A: It offers lower prices through direct-to-consumer sales, increasing price competition.

Q5: Which regions present the most growth opportunity?
A: Asia-Pacific and other emerging markets with rising skin-related conditions and less regulation.

References

[1] MarketWatch. (2022). Dermatological market size and growth.
[2] Retail Pharmacy Pricing Reports. (2022). OTC product price analysis.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.